COVID-19、高血糖与新发糖尿病
COVID-19患者中糖尿病等慢性共病高发且与重症和死亡风险增加相关;轻度血糖升高常见且与不良结局相关。近期多项研究报道COVID-19相关新发糖尿病,机制可能涉及未诊断糖尿病、应激性高血糖、类固醇性高血糖及SARS-CoV-2对β细胞的直接或间接影响,需研究指导管理路径。
要点
- COVID-19患者常见轻度血糖升高,即使无糖尿病也与不良结局相关。
- 新发糖尿病机制未明,可能涉及未诊断糖尿病、应激性高血糖、类固醇性高血糖及SARS-CoV-2对β细胞影响。
- 住院方案应识别和管理急性高血糖包括糖尿病酮症酸中毒,因新发糖尿病死亡率增加。
核心结论
- COVID-19患者中新发糖尿病与死亡率增加相关,但长期是否永久未知,需前瞻性研究明确病因、预后和治疗机会。
研究设计与样本
- 本文为综述,未报告系统检索范围与样本量。
主要发现
- 糖尿病等慢性共病在COVID-19患者中高发,与重症和死亡风险增加相关。
- 轻度血糖升高在COVID-19患者中常见,即使无糖尿病也与更差结局相关。
- 近期多项研究报道COVID-19相关新发糖尿病,但精确机制未明。
临床怎么用
- 住院方案应包含识别和管理急性高血糖(包括糖尿病酮症酸中毒)的措施。
- 需研究指导COVID-19相关新发糖尿病的管理路径。
局限性
- 新发糖尿病长期随访有限,是否永久未知。
- 新发糖尿病精确机制未明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Certain chronic comorbidities, including diabetes, are highly prevalent in people with coronavirus disease 2019 (COVID-19) and are associated with an increased risk of severe COVID-19 and mortality. Mild glucose elevations are also common in COVID-19 patients and associated with worse outcomes even in people without diabetes. Several studies have recently reported new-onset diabetes associated with COVID-19. The phenomenon of new-onset diabetes following admission to the hospital has been observed previously with other viral infections and acute illnesses. The precise mechanisms for new-onset diabetes in people with COVID-19 are not known, but it is likely that a number of complex interrelated processes are involved, including previously undiagnosed diabetes, stress hyperglycemia, steroid-induced hyperglycemia, and direct or indirect effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the β-cell. There is an urgent need for research to help guide management pathways for these patients. In view of increased mortality in people with new-onset diabetes, hospital protocols should include efforts to recognize and manage acute hyperglycemia, including diabetic ketoacidosis, in people admitted to the hospital. Whether new-onset diabetes is likely to remain permanent is not known, as the long-term follow-up of these patients is limited. Prospective studies of metabolism in the setting of postacute COVID-19 will be required to understand the etiology, prognosis, and treatment opportunities.
引用
- Khunti K, Del Prato S, Mathieu C, et al. COVID-19, Hyperglycemia, and New-Onset Diabetes. Diabetes Care. 2021. PMID: 34625431. doi:10.2337/dc21-1318
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。